Episode

Myth vs Medicine: Pharmacist’s Perspective on Adjuvant CDK4/6 Inhibitor Optimization

Podcast

Decera Clinical Education Oncology Podcast

Published

Mar 20, 2026

Duration seconds

1511

Processing state

not_requested

Canonical source

https://oncologypodcast.simplecast.com/episodes/myth-vs-medicine-pharmacists-perspective-on-adjuvant-cdk4-6-inhibitor-optimization-EWbEJ_1v

Audio

https://afp-928689-injected.calisto.simplecastaudio.com/1d8e143b-904e-45be-b6c5-8fba793d9d74/episodes/8c96b42f-7480-42b6-83fb-4ddc615809d6/audio/128/default.mp3?aid=rss_feed&awCollectionId=1d8e143b-904e-45be-b6c5-8fba793d9d74&awEpisodeId=8c96b42f-7480-42b6-83fb-4ddc615809d6&feed=GlfUTtJq

JSON

/v1/public/podcasts/decera-clinical-education-oncology-podcast-1302999/episodes/myth-vs-medicine-pharmacist-s-perspective-on-adjuvant-cdk4-6-inhibitor-optimization

Markdown

/podcast/decera-clinical-education-oncology-podcast-1302999/myth-vs-medicine-pharmacist-s-perspective-on-adjuvant-cdk4-6-inhibitor-optimization.md

Actions

• POST https://stenobird.com/v1/public/podcasts/decera-clinical-education-oncology-podcast-1302999/episodes/myth-vs-medicine-pharmacist-s-perspective-on-adjuvant-cdk4-6-inhibitor-optimization/transcription-requests
  Idempotently request low-priority transcript generation for this episode.
• GET https://stenobird.com/podcast/decera-clinical-education-oncology-podcast-1302999/myth-vs-medicine-pharmacist-s-perspective-on-adjuvant-cdk4-6-inhibitor-optimization.md
  Read the agent-friendly Markdown representation of this episode resource.

Summary

Listen to oncology pharmacists, Julia L. Ziegengeist, PharmD, BCOP, and Rodney Hunter, PharmD, BCOP, discuss assumptions about adjuvant CDK4/6 inhibitor use in high-risk HR+/HER2- early breast cancer, providing their experiences using these therapies for their patients with early-stage breast cancer.